ArticleFrontiers in surgery2025
Development and validation of a nomogram for predicting the efficacy of vidian neurectomy in the treatment of chronic rhinosinusitis with nasal polyps combined with allergic rhinitis.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vidian neurectomy (VN) is commonly used to treat chronic rhinosinusitis with nasal polyps combined with allergic rhinitis (CRSwNP with AR). However, its therapeutic efficacy varies among individuals. This study aimed to develop a nomogram to predict treatment efficacy and provide reference for clinical decision-making. Methods: A total of 350 patients with CRSwNP and AR who underwent VN were retrospectively enrolled and divided into effective and ineffective groups based on treatment outcomes. Univariate analysis was performed to compare demographic and disease-related characteristics between the two groups. Significant variables from the univariate analysis were included as predictors in an XGBoost model, with SHAP visualization used to identify important features. In parallel, multivariate logistic regression was conducted to determine independent predictors of efficacy. Variables identified as both important and statistically significant from these two methods were used to construct a nomogram. The performance of the nomogram was evaluated using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). Results: The effective group accounted for 74.57% of the cohort. The ineffective group showed significantly higher values in several indicators, including disease duration, history of endoscopic sinus surgery, inflammatory markers, and symptom scores. Both the XGBoost model and multivariate logistic regression identified preoperative white blood cell count (WBC), operation duration, history of endoscopic sinus surgery, total IgE level, and SNOT-22 score as significant predictors (all Conclusion: This study successfully developed and validated a nomogram incorporating preoperative WBC, operation duration, prior surgical history, total IgE, and SNOT-22 score to predict the efficacy of VN in treating patients with CRSwNP and AR. The model offers a reliable tool to assist clinicians in making personalized treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.